Ovarian Cancer Flashcards

1
Q

Some people are at a higher genetic risk of developing ovarian cancer, who are these groups?[2]

A

HNPCC/ Lynch Type II Familial cancer syndrome
BRCA 1 and BRCA 2 (TSGs)
- 15-45% lifetime risk of Ovarian Cancer, early onset of breast and ovarian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors of ovarian cancer other than genetic factors [4]

A
Incessant ovulation hypothesis
Asbestos exposure
Endometriosis
Diabetes, PCOS
Unopposed estrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does Ovarian Cancer present? [5]

Age

A

Very vague symptoms
Indigestion, early satiety, poor appetite
Altered bowel habit/pain
Bloating, discomfort, weight gain
Pelvic mass - asymptomatic or pressure symptoms
PV bleeding
Age <30yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ovarian cancer investigations? [5]

A

Start with an abdo > pelvic US
US guided biopsy of omentum to obtain needle cores
CT staging
Tumor markers: CA125 if >40yo, AFP LDH HCG if <40yo
Laparospic exploration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is CA 125? [2]
Elevated in other cancers [4]
Benign conditions with elevated CA125 [3]

A
A serum biomarker that is a glycoprotein antigen
Elevated in other cancers: 
Endometrial ca, fallopian tube ca
Breast ca
Lung ca
GI cancer

Benign conditions with elevated CA125:
Any pathology that irritates peritoneum
Menstruation, endometriosis, PID
Liver disease, recent surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk of malignancy index is used to estimate likelihood of individual having cancer: [3]
NB not diagnostic

A

With a risk of malignancy index (RMI): US x M x CA125
US - US features of malignancy [5]
M - Menopausal status - yes = 1, no = 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What US features apply to the RMI? [5]

A

1 feature = 1point
2+ = 3 points

  • Multi-locular
  • Solid areas
  • Bilateral
  • Ascites
  • Intra-abdominal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Whats an abnormal CA125?

A

> 200 is considered a significant risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is Ovarian cancer treated? [3]

A

Chemotherapy - first line drugs are platinum, taxane

Surgical removal - laporotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What if ovarian cancer recurs? [3]

A

2nd line chemo often palliative
Repeat surgery - where further resection would benefit patient, can build up chemotherapy reserve for chemo later on
Tamoxifen if cannot tolerate systemic chemotherapy ie if elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ovarian cancer staging [4]

A

FIGO stages - pathology after surgery:
1 = Limited to ovaries with capsule intact
2 = One or both ovaries with pelvic extension
3 = One or both ovaries with peritoneal implants outside pelvis or positive nodes
4 = Distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who would we screen for ovarian cancer?

A

Only high risk women i.e.:

  • Carrying BRCA genes or HNPCC
  • 2+ relatives with OC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we screen for ovarian cancer? [3]

A

Pelvic exam, US, CA125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What can we do for very high risk women?

A

Prophylactic Oophorectomy once they’re done having family, usually around 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA platinum based drugs
Give 3 eg of platinum based drugs
MOA taxanes [2]

A

Platinum based drugs MOA: form highly reactive platinum complexes that bind and crosslink DNA causing cancer cell apoptosis e.g. cisplatin, carboplatin, oxaliplatin

Taxanes - block cell cycle progression through centrosomal, impairment induction of abnormal spindles and suppression of spindle microtubule dynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Laporotomy as treatment for ovarian cancer - aims [4]

A

○ Removing all naked-eye diseases, disease clearance and debulking
○ Obtain tissue diagnosis
○ Stage disease
○ Disease clearance

17
Q

Protective factors [4]

A

pregnancy, breastfeeding, COCP, tubal ligation

18
Q

Signs of ovarian cancer [5]

A
Pelvic/abdominal mass
Omental mass
Ascites
Pleural effusion
Supraclavicular lymph node enlargement
19
Q

Classification [3] Give 3 examples of each

A

Sex cord stromal ovarian cancer

  • Granulosa theca cell
  • Fibromas (Meig’s)
  • Sertoli-Leydig cell

Germ cell ovarian cancer

  • Teratomas eg struma ovarii
  • Choriocarcinoma (placental tissue)
  • Dysgermioma (oocyte tumor)

Epithelial ovarian cancer

  • Serous
  • Mucinous
  • Endometrioma
  • Transitional cell
20
Q

Mucinous adenomas clinical features [4]

A

CA19.9
Large tumours
Appendix removed at same time
Associated with malignant pseudomyxoma peritonei

21
Q

Meig’s syndrome triad [3]

A

Right sided ovarian fibroma
Pleural effusion
Ascites

22
Q

Investigations of benign ovarian tumours [5]

A
FBC
Tumour markers: BHCG, CA125, CA19.9
TVUSS
TAUSS
MRI
23
Q

Management of pre-menopausal lady with pelvic mass

A
Re-scan in 6w
Discharge:
- No features of malignancy
- Cyst <5cm
Laparoscopic cystectomy:
- If >5cm, symptomatic
- Features of endometrioma or dermoid cyst
24
Q

Management of post-menopausal lady with pelvic mass [4]

A
Calculate RMI, stratify her risk
Low risk cysts <5cm:
- Conservative mx with repeat TVUSS and CA125 every 4m 
Moderate risk cysts:
- Bilateral oophorectomy
High risk cysts:
- Staging laparotomy
25
Q

When would you discharge a post-menopausal lady with suspected benign ovarian tumors?

A

Discharge if no change on TVUSS and CA125 in 1 year